Back to All Topics
Mechanisms
Research Article
2 min read
Tissue-Specific Peptide Effects
How peptides exert different effects in various tissues based on receptor distribution.
Introduction
Peptides produce varied effects depending on tissue-specific receptor expression and signaling.
Tissue Distribution of Key Receptors
GH/GHS Receptors
| Tissue | GHR Density | GHS-R1a | Primary Effect |
|---|---|---|---|
| Liver | Very high | Low | IGF-1 production |
| Muscle | High | Low | Protein synthesis |
| Fat | High | Low | Lipolysis |
| Pituitary | Moderate | Very high | GH release |
| Hypothalamus | Moderate | High | Appetite regulation |
IGF-1 Receptors
| Tissue | IGF-1R Density | Primary Effect |
|---|---|---|
| Muscle | Very high | Hypertrophy |
| Bone | High | Growth/density |
| Cartilage | High | Repair |
| Fat | Moderate | Variable |
Peptide-Specific Tissue Effects
GH Secretagogues
| Tissue | Effect | Significance |
|---|---|---|
| Pituitary | GH release | Primary target |
| Liver | IGF-1 production | Systemic effects |
| Muscle | Anabolism | Growth |
| Fat | Lipolysis | Body composition |
| Brain | Neuroprotection | Potential benefit |
BPC-157
| Tissue | Effect | Mechanism |
|---|---|---|
| GI tract | Healing | Primary action site |
| Tendons | Repair | Growth factor effects |
| Muscle | Regeneration | Angiogenesis |
| Blood vessels | Angiogenesis | VEGF pathway |
| Nervous system | Protection | Multiple pathways |
TB-500
| Tissue | Effect | Mechanism |
|---|---|---|
| All tissues | Cell migration | Actin sequestering |
| Heart | Repair | Angiogenesis |
| Muscle | Regeneration | Satellite cell effects |
| Tendons | Healing | Collagen |
Targeted Administration
Site-Specific Injection
| Strategy | Application | Benefit |
|---|---|---|
| Near injury | BPC-157, TB-500 | Concentrated effect |
| Subcutaneous abdominal | GH peptides | Standard |
| Intramuscular | Some protocols | Debated benefit |
Systemic vs. Local Effects
| Peptide | Administration | Distribution |
|---|---|---|
| GH secretagogues | Subcutaneous | Systemic |
| BPC-157 | Near site or systemic | Both effective |
| TB-500 | Any site | Systemic distribution |
| IGF-1 LR3 | Intramuscular or SubQ | Systemic |
Optimization Based on Goals
| Goal | Focus Tissue | Best Peptides |
|---|---|---|
| Muscle growth | Muscle | GH secretagogues, IGF-1 |
| Tendon healing | Connective tissue | BPC-157, TB-500 |
| Fat loss | Adipose | Fragment 176-191 |
| General recovery | Multiple | Combination approach |
Conclusion
Understanding tissue specificity guides peptide selection and administration strategies.
Stay Updated on Peptide Research
Get weekly breakdowns of new studies, dosing insights, and community protocols. No spam, unsubscribe anytime.